The Pistoia Alliance is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing ...

Collaboration efforts will reduce manual burden of adverse event reporting, enable ethical AI use and accelerate innovation in drug safety monitoring Boston, 23rd July 2025: The Pistoia Alliance, a ...

An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing ...

Pharmacoeconomics & Real-World Evidence take centrestage in India’s regulatory decision-making: Nandita Vijayasimha, Bengaluru Monday, July 28, 2025, 08:00 Hrs [IST] India is un ...

The Liberia Chapter of the West African Postgraduate College of Pharmacists (WAPCP) was officially launched in Monrovia over the weekend with a call for greater support from the Government of Liberia ...

Discover the revolutionary impact of generative artificial intelligence (GenAI) on drug safety in pharmacovigilance. Learn how this cutting-edge technology is transforming the industry.

To find out first-hand how pharma tackles safety and pharmacovigilance, we speak with Alan Morrison, who is Amgen's Vice President of Global Regulatory Affairs and Safety.